A detailed history of State Of Tennessee, Treasury Department transactions in Abb Vie Inc. stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 679,388 shares of ABBV stock, worth $122 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
679,388
Previous 684,505 0.75%
Holding current value
$122 Million
Previous $117 Million 14.27%
% of portfolio
0.48%
Previous 0.44%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $838,369 - $1.02 Million
-5,117 Reduced 0.75%
679,388 $134 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $2.63 Million - $3.07 Million
-16,995 Reduced 2.42%
684,505 $117 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $6.67 Million - $7.6 Million
-41,745 Reduced 5.62%
701,500 $128 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $5.5 Million - $6.19 Million
39,954 Added 5.68%
743,245 $115 Million
Q2 2023

Aug 15, 2023

SELL
$132.51 - $164.9 $5.74 Million - $7.15 Million
-43,350 Reduced 5.81%
703,291 $94.8 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $7.99 Million - $9.2 Million
-55,246 Reduced 6.89%
746,641 $119 Million
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $8.47 Million - $10.2 Million
-61,221 Reduced 7.09%
801,887 $130 Million
Q3 2022

Jan 26, 2023

SELL
$134.21 - $153.93 $2.95 Million - $3.39 Million
-22,012 Reduced 2.49%
863,108 $116 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $22.1 Million - $28 Million
-160,252 Reduced 15.33%
885,120 $136 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $14.1 Million - $17.5 Million
106,909 Added 11.39%
1,045,372 $169 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $40 Million - $50.6 Million
372,553 Added 65.83%
938,463 $127 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $47.6 Million - $54 Million
-447,116 Reduced 44.14%
565,910 $61 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $3.75 Million - $4.17 Million
35,599 Added 3.64%
1,013,026 $114 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $27.2 Million - $30 Million
-266,337 Reduced 21.41%
977,427 $106 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $57 Million - $77 Million
708,545 Added 132.38%
1,243,764 $133 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $50.2 Million - $59 Million
-584,869 Reduced 52.22%
535,219 $46.9 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $35.1 Million - $46.9 Million
478,035 Added 74.45%
1,120,088 $110 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $16.9 Million - $25.7 Million
-262,538 Reduced 29.02%
642,053 $48.9 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $2.99 Million - $3.74 Million
41,391 Added 4.8%
904,591 $80.1 Million
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $30.7 Million - $37 Million
-488,088 Reduced 36.12%
863,200 $65.4 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $20.6 Million - $26.3 Million
313,736 Added 30.24%
1,351,288 $98.3 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $6.3 Million - $7.41 Million
-81,648 Reduced 7.3%
1,037,552 $83.6 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $5.36 Million - $6.61 Million
-68,829 Reduced 5.79%
1,119,200 $103 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $18.5 Million - $20.6 Million
208,571 Added 21.29%
1,188,029 $112 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $14.5 Million - $17.1 Million
-161,223 Reduced 14.13%
979,458 $90.7 Million
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $7.3 Million - $9.78 Million
79,372 Added 7.48%
1,140,681 $108 Million
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $1.09 Million - $1.2 Million
12,183 Added 1.16%
1,061,309 $103 Million
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $73.3 Million - $93.6 Million
1,049,126
1,049,126 $93.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.